475
Badr et al.
Table 4. Analytical, spectral, and physical data of compounds 10a, 10b and 18a, 18b.
Analysis calcd./found (%)
Spectral data
Comp.
no.
Yield
%
Mol.
mp, °Ca Color
formula
C
H
N
S
IR (K Br) cm–1
(CO) 1650
1H NMR δ (ppm) and MS, m/z (%)
1H NMR (TFA-d) δ: 2.70 (s, 3H, p-CH3),
2.90 (s, 3H, CH3), 8.98 (s, 1H, =CH),
7.4–9.9 (m, 14H, ArH)
Pale
70.30 3.93 16.40 6.26
10a
10b
18a
325°C yellow
74
78
81
C30H20N6OS 70.04 4.20 13.21 6.40
1H NMR (TFA-d) δ: 2.70 (s, 3H, p-CH3),
2.93 (s, 3H, CH3), 4.20 (s, 3H, p-OCH3),
7.1–9.8(m, 13H, ArH+ 1H, =CH)
68.62 4.09 15.49 5.91
315°C Yellow
320°C Yellow
C31H22N6O2S 68.39 4.10 15.67 6.08
(CO) 1660
(NH) 3250
1H NMR (TFA-d) δ: 2.30 (s, 3H, p-CH3),
2.63 (s, 3H,CH3), 4.15 (s, 3H, p-OCH3),
8.50 (s, 1H, =CH), 7.1–9.9 (m, 12H, ArH)
68.74 4.28 18.10 5.92
C31H23N7OC 68.48 4.40 17.89 5.78
1H NMR (TFA-d) δ: 2.20 (s, 3H, p-CH3),
2.64 (s, 3H, CH3), 7.7–9.8 (m, 13H,
ArH + H, = CH)
Pale
64.50 3.61 20.06 5.74
18b
330°C yellow
74
C30H20N8O2S 64.69 3.81 19.91 5.48
(NH) 3210
a All products were recrystallized from ethanol.
1H NMR (TFA-d) δ: 2.50 (s, 3H, p-CH3), 2.95 (s, 3H, CH3),
3.20 (s, 3H, CH3 triazol), 7.2–9.7 (m, 8H, ArH). Anal. calcd.
for C25H17N7S: C 67.10, H 3.83, N 21.91, S 7.17; found: C
63.70, H 4.05, N 22.10, S 6.98%.
11-(Arylidenehydrazono)-9-methyl-7-(p-tolyl)pyrimido-
[4′′,5′′:4′,5′]thieno-[3′,2′:5,6]pyrido[3,2-c]cinnoline
(18a and 18b)
The hydrazino compound 13 and each of (a) p-anisaldehyde
and (b) p-nitrobenzalehyde (0.001 mol) in acetic acid (20 mL)
were refluxed for 30 min. The solid product was filtered and
recrystallized from ethanol. The analytical, spectral, and
physical data are reported in Table 4.
References
1. S. Kneubuehler, V. Carta, A. Vincengo, C. Altomare,
A. Carotti, and B. Testa. Helv. Chim. Acta, 76, 1956(1993);
T. Nakao, M. Kawakami, M. Hisadome, and T. Tahara. PCT Int.
Appl. WO 89 04,306, 18 May, 1989; JP Appl. 87/278,009, 2
Nov. 1987; Chem. Abstr. 111, 214498 (1989).
2. S. Inoue, A. Yazaki, H. Mochizuki, H. Tsutsumi, M. Murata,
and K. Sakane. Jpn. Kokai Tokkyo Koho, JP 06 228, 138[94,
228, 138]; Chem. Abstr. 123, 9452 (1995); S. Inoe, J. Yoshida,
M. Yokomoto, A. Yazaki, N. Hayashi, and H. Amano. Jpn.
Kokai Tokkyo Koho, JP 06, 228, 138 [94, 228, 138], JP Appl.
92/22, 407; Chem. Abstr. 121, 179602 (1994); M. Yokomoto,
A. Yazaki, N. Hayashi, S. Hatono, S. Inoue, and Y. Kuramato.
Eur. Pat. Appl. Ep 470, 578; JP Appl 90/211, 190; Chem. Abstr.
117, 7943(1992); R. Fusco, L.F. Piselli, and P.M. Boschi. Eur.
Pat. Appl. Ep 287, 853 IT Appl. 87/20,230; Chem. Abstr. 110,
75540 (1989); T. Miyamoto and J. Matsumoto. Chem. Pharm.
Bull. 37, 93 (1989); 36, 1321 (1988).
5-Methyl-7-(p-tolyl)tetrazolo[4′′′,3′′′:1′′,6′′]pyrimido-
[4′′,5′′:4′,5′]thieno- [3′,2′:5,6]pyrido[3,2-c]cinnoline (19)
Sodium nitrite (7 mL, 10%, 0.01 mol) was added dropwise to
a solution of the hydrazino derivative 13 (0.002 mol) in dilute
hydrochloric acid (10 mL, 50%) at 0°C and stirred for 10 min.
The solid product separated and recrystallized from ethanol as
pale yellow crystals, mp >360°C, yield 70%. IR: NH and NH2
1
absorptions disappeared. H NMR (TFA-d) δ: 2.65 (s, 3H,
p-CH3), 3.30 (s, 3H, CH3), 7.4–9.95 (m, 8H, ArH). Anal. calcd.
for C23H14N8S: C 63.58, H 3,25, N 25.79, S 7.38; found: C
63.30, H 3.40, N 25.37, S 7.19%.
5-Methyl-7-(p-tolyl)-1,2,4-triazolo[4′′′,3′′′:1′′,6′′]pyrimido-
[4′′,5′′:4′,5′]thieno-[3′,2′:5,6]pyrido[3,2-c]cinnolin-
3(2H)-one (20)
3. M. Mizutani, M. Shiroshita, M. Sasaki, H. Okuda, and N. Mito.
Eur. Pat. Appl. EP 273, 325; JP Appl. 86/309, 981; Chem. Abstr.
110, 75532 (1989).
The hydrazino compound 13 (0.001 mol) and ethyl chlorofor-
mate (0.002 mol) in acetic acid (20 mL) were refluxed for
30 min. The solid product was recrystallized from acetic acid
as yellow crystals, mp 300°C, yield 66%. IR: 1725 (CO), 3400
(NH) cm–1. 1H NMR (TFA-d) δ: 2.60 (s, 3H, p-CH3), 2.95 (s,
3H, CH3), 7.45–9.8 (m, 8H, ArH). MS, m/z (%): 449 (M+, 4).
Anal. calcd. for C24H16N7OS: C 24.0, H 3.28, N 21.76, S 7.12;
found: C 64.20, H 3.76, N 21.58, S 6.96%.
4. G.A. Pinna, M.M. Curzu, G. Cignarella, D. Barlocco,
M. D’Amico, A. Filippelli, V. DeNovellis, and F. Rossi. Eur. J.
Med. Chem. 29, 447 (1994); G. Cignarella, D. Barrlocco,
S. Villa, M.M. Curzu, G.A. Pinna, A. Lavezzo, and A. Bestetti.
27, 819 (1992); G. Cignarella, D. Barlocco, M.M. Curzu,
G.A. Pinna, P. Cazzulani, M. Cassin, and B. Lumachi. Eur. J.
Med. Chem. 25, 749,(1990); G. Cignarella, D. Barlocco,
G.A. Pinna, M. Loriga, M.M. Curzu, O. Toffametti, M. Ger-
mini, P. Cazzulani, and E. Cavelletti. J. Med. Chem. 32, 2277
(1989).
3,5-Dimethyl-7-(p-tolyl)-1,2,4-triazolo[4′′′,3′′′:1′′,6′′]pyrimido-
[4′′,5′′:4′,5′]- thieno[3′,2′:5,6]pyrido[3,2-c]cinnoline (21)
The hydrazino compound 13 (0.001 mol) and acetic anhydride
(20 mL) were refluxed for 6 h. The solid product was recrys-
tallized from acetic acid as greenish yellow crystals, mp
>360°C, yield 71%. IR: NH and NH2 absorptions disappeared.
5. N. Garcia-Dominguez, E. Ravina, L. Santana, C. Teran, G. Gar-
cia-Mera, F. Orallo, M. Crespo, and J.A. Fontenla. Arch. Pharm.
321, 735 (1988).
6. J.F. Patoiseau, J.M. Autin, J.L. Maurel, and D. Bigg. PCT Int.
Appl. Wo 93/09, 098, FR Appl. 91/13,571; Chem. Abstr. 119,
© 1998 NRC Canada